Ixempra 45mg Injection

Visão geral do produto

About Ixempra

Ixempra is a medication containing the active ingredient Ixabepilone. Ixabepilone is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Ixabepilone, the active ingredient in Ixempra, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Ixempra. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Ixempra for extended periods without medical advice.